Internal Medicine, Medical Oncology · Humble, TX
NPI
1568527927
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
18960 N Memorial Dr
Humble, TX, 77338
Phone (281) 540-6260
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
72,195 services
Medicare patients, 2024
203
Average age 73
Drug cost, 2024
$3.5M
1,565 prescriptions
Company payments, 2025
$5,220
From 51 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bhuvana Sagar was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 16,320 times for 15 patients. In total Bhuvana Sagar billed 72,195 services in 110 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 16,320 | 15 | $0.26 | $4,325 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 420 | 11 | $0.66 | $279 |
| 85025 Blood Count | Office | 316 | 119 | $7.59 | $2,398 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 264 | 141 | $12.94 | $3,416 |
| 99215 Office E&M - Established | Office | 161 | 49 | $140.36 | $23K |
| 96372 Injection Administration | Office | 147 | 27 | $11.09 | $1,630 |
| 99213 Office E&M - Established | Office | 146 | 90 | $66.38 | $9,692 |
| 99214 Office E&M - Established | Office | 130 | 81 | $97.77 | $13K |
| 96413 Chemotherapy Administration | Office | 110 | 21 | $99.71 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 109 | 13 | $22.39 | $2,441 |
| 96375 Injection Administration | Office | 61 | 11 | $12.17 | $742 |
| 99204 Office E&M - New | Office | 55 | 55 | $124.35 | $6,839 |
| 96365 Intravenous Infusion, Hydration | Office | 49 | 24 | $48.69 | $2,386 |
| 99205 Office E&M - New | Office | 46 | 46 | $164.48 | $7,566 |
| 36415 Venipuncture Blood Collection | Office | 34 | 18 | $8.65 | $294 |
By year: 2022 $36K for 9,068 services; 2023 $551K for 31,658 services; 2024 $1.3M for 72,195 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 316 | 119 | $7.59 | $2,398 |
| 36415 Venipuncture Blood Collection | 34 | 18 | $8.65 | $294 |
Medicare prescription drug claims, 2024
In 2024, the drug Bhuvana Sagar prescribed most often to Medicare patients was Anastrozole, with 89 prescriptions and refills. In total Bhuvana Sagar wrote 1,565 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 89 | 224 | 36 | $1,422 |
| Dexamethasone Generic | 71 | 74 | 41 | $1,612 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 62 | 28 | $1,653 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 61 | 61 | 54 | $659 |
| Ondansetron Odt Ondansetron | 60 | 60 | 52 | $1,541 |
| Famciclovir Generic | 57 | 85 | 11 | $2,883 |
| Granisetron Hcl Generic | 50 | 50 | 44 | $11K |
| Duloxetine Hcl Generic | 50 | 52 | 21 | $667 |
| Aprepitant Generic | 47 | 47 | 12 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 69 | 14 | $195 |
| Loperamide Loperamide Hcl | 43 | 44 | 39 | $582 |
| Levothyroxine Sodium Generic | 43 | 59 | 14 | $211 |
| Morphine Sulfate Er Morphine Sulfate | 42 | 42 | 14 | $1,274 |
| Olanzapine Generic | 39 | 39 | 20 | $148 |
| Exemestane Generic | 37 | 102 | 14 | $5,486 |
Brand drugs: - claims; generic drugs: 1,250 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bhuvana Sagar $5,220 ($5,220 in general payments such as food, travel and fees) from 51 companies. The largest payer was Janssen Biotech, Inc. with $444.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 15 | $444 |
| Merck Sharp & Dohme LLC MRK | 14 | $368 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $303 |
| Astellas Pharma US Inc 4503.T | 12 | $296 |
| Tempus AI, Inc TEM | 12 | $278 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $246 |
| Pfizer Inc. PFE | 9 | $203 |
| Eisai Inc. 4523.T | 8 | $194 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $191 |
| Daiichi Sankyo Inc. 4568.T | 5 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.